Mainz Biomed supports Colorectal Cancer Awareness Month

Mainz Biomed (MYNZ) supports Colorectal Cancer Awareness Month in March. Detecting colorectal cancer in its early stages significantly improves survival rates, making awareness and proactive screening essential in the fight against this disease. Globally, CRC is the second leading cause of cancer-related deaths, with over 930,000 fatalities annually. In the U.S. it is estimated that over 150,000 people were diagnosed with colorectal cancer, and in Germany, approximately 22,836 individuals succumb to CRC each year, accounting for a substantial portion of cancer-related mortality in the country.